ClinicalTrials.gg
CompletedNCT06090968Updated Jul 9, 2024

Umbilical Cord Milking Versus Immediate Cord Clamping in Full Term Neonates (≥ 37 Weeks) Requiring Resuscitation

An interventional study of Umbilical cord milking and Immediate cord clamping in Hypoxic-Ischemic Encephalopathy and Perinatal Asphyxia, sponsored by Lady Hardinge Medical College. Completed at 1 site in India. Open to participants aged 37 Weeks to 41 Weeks. Per ClinicalTrials.gov, last updated 2024-07-09.

Sponsored by Lady Hardinge Medical College · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 1 year 8 months after the study started (first participant enrolled Feb 2022, registered Oct 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
37 Weeks to 41 Weeks
Sex
All
01

Study summary

The objective of the study is to compare the incidence of Hypoxic ischemic encephalopathy (all stages) among singleton term neonates (≥ 37 weeks) requiring resuscitation who will undergo Umbilical cord milking as compared to Immediate cord clamping.

Read the detailed description

Enrolled participants will be randomly allocated to one of two study groups: 1) Umbilical cord clamping, 2) Immediate cord clamping

Umbilical cord clamping group: In the babies requiring resuscitation during vaginal delivery, the delivering obstetrician will place the infant on the mother's abdomen and about 20 cm of umbilical cord would be milked towards the infant with intact umbilical cord. The cord milking will be done four times by the obstetrical provider or by a second team member at the rate of 20 cm/2 sec. This procedure can be done in 15-20 seconds. Length of 20 cm can be estimated by the length of a sponge holding forceps which is approximately 25 cm. The umbilical cord will then clamped 2 -3 cm from the umbilical stump.

Immediate cord clamping: This will occur by clamping the umbilical cord as soon as possible (average 30 seconds).

Further resuscitation will be done in accordance with NRP 2015 guidelines. Stop watch will be used to calculate the duration after which the cord is clamped and cut, time to first breath, and time required to achieve HR > 100/min

02

Conditions studied

  • Hypoxic-Ischemic Encephalopathy
  • Perinatal Asphyxia
03

In context

Hypoxia-Ischemia, Brain

261 studies on the registry are indexed under Hypoxia-Ischemia, Brain; 95 are open to participants now.

This study's enrollment of 200 is above the median of 50 across 156 interventional studies indexed under Hypoxia-Ischemia, Brain.

Browse Hypoxia-Ischemia, Brain studies →

Lead sponsor

Lady Hardinge Medical College is the lead sponsor of 34 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
37 Weeks to 41 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Vaginally born, Singleton Term gestation (≥ 37 and \& \< 42 weeks), requiring resuscitation at birth

Exclusion criteria

Exclusion Criteria:

  • Major congenital anomaly (antenatally diagnosed or visible at birth)
  • Rh negative pregnancy
  • Hydrops
  • Abruptio Placneta/ Placenta previa
  • Fetus with absent and reversal of End Diastolic flow
  • Cord avulsion
  • Refusal of consent
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
200 participants (actual)

Study arms

  • Experimental
    Umbilical cord milking

    20 cm of umbilical cord would be milked towards the infant with intact umbilical cord. The cord milking will be done four times. The entire procedure can be done in 15-20 seconds

    Procedure: Umbilical cord milking

  • Active comparator
    Immediate cord clamping

    clamping the umbilical cord as soon as possible (average 30 seconds)

    Procedure: Immediate cord clamping

Interventions

  • ProcedureUmbilical cord milking

    20 cm of umbilical cord would be milked towards the infant with intact umbilical cord. The cord milking will be done four times. The entire procedure can be done in 15-20 seconds

  • ProcedureImmediate cord clamping

    clamping the umbilical cord as soon as possible (average 30 seconds)

06

What researchers measure

Primary outcomes

  1. Incidence of Hypoxic Ischemic Encephalopathy

    any stage as per Sarnat and Sarnat Staging

    Time frame: From date of birth until date of death from any cause whichever come first assessed till 1 week of life

Secondary outcomes

  1. Proportion requiring NICU admission

    NICU admission due to any reason

    Time frame: Till 1 week of life

  2. Level of hypoxic ischemic encephalopathy ( mild, moderate or severe)

    Level of hypoxic ischemic encephalopathy as per Sarnat and Sarnat Staging

    Time frame: From date of birth until date of death from any cause whichever come first assessed till 1 week of life

  3. Received blood products or saline bolus or inotropes to support blood pressure

    Hypotension requiring blood products or saline bolus or inotropes

    Time frame: From date of birth until date of death from any cause whichever come first assessed till 1 week of life

  4. Length of hospital stay

    Duration of stay in days

    Time frame: From date of birth until date of death from any cause whichever come first assessed till 4 week of life

  5. Mean Blood Pressure at 2,6,12,24,48,72 hrs

    Mean Blood Pressure as assessed by non-invasive oscillometric method

    Time frame: From date of birth until date of death from any cause whichever come first assessed till 72 hours of life

  6. Hyperbilirubinemia requiring phototherapy

    As per AAP charts

    Time frame: From date of birth until date of death from any cause whichever come first assessed till 4 week of life

  7. Proportion of neonates having APGAR score < 4 at 5 minutes of life

    APGAR score (Min zero maximum Ten) assessed at 1,5 minutes (Low APGAR is bad prognosis and High APGAR is good prognosis)

    Time frame: Till 5 minutes of life

  8. Neonates requiring Initial steps of resuscitation, Bag and Mask Ventilation, Intubation, chest compression and administration of drugs during resuscitation.

    As per NRP 2015 guidelines

    Time frame: Till 1 minutes of life

  9. Proportion of neonates developing polycythemia

    Polycythemia is defined as venous hematocrit \>65%

    Time frame: Till first 72 hours

  10. Proportion of mortality due to any cause

    Including early and late neonatal deaths

    Time frame: From date of birth until date of death from any cause whichever come first assessed till 4 week of life

07

Study locations

1 site
  • Lady Hardinge Medical college
    New Delhi, Delhi 110001, India
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2022 to primary completion in Feb 2024, 23 months.

Of 46 non-industry interventional studies with no phase under Hypoxia-Ischemia, Brain, half reached primary completion within 33 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 63. This study's 23 months is below that.

Counting every sponsor, half of 47 studies reached it within 33 months; a quarter within 19 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 13, 2023
First posted
Oct 19, 2023
StartActual
Feb 5, 2022
Primary completionActual
Feb 4, 2024
CompletionActual
Mar 4, 2024
Last update
Jul 9, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 9, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06090968
Lead sponsor
Lady Hardinge Medical College
Responsible party
Sushma Nangia, M.D. (Dr. Sushma Nangia, Director Professor & Head, Department of Neonatology, Lady Hardinge Medical College) — Principal investigator
First posted
Oct 19, 2023
Start date
Feb 5, 2022
Primary completion
Feb 4, 2024
Completion
Mar 4, 2024
Last update
Jul 9, 2024

Study contacts

Sushma Nangia, DM (Neo)
study chair · Lady Hardinge Medical College, New Delhi, India

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion